Survey of Post-Acute Inpatient Rehabilitation Safety Concerns in Participants With Cancer
NCT ID: NCT03656224
Last Updated: 2021-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
261 participants
OBSERVATIONAL
2018-08-29
2021-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Expectations Regarding Mobility and Self-Care
NCT02911064
Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center
NCT03671226
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
NCT06329531
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors
NCT00335491
Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
NCT02017925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Assess patients' perceptions regarding safety after acute inpatient rehabilitation at discharge and after approximately one month from discharge date.
SECONDARY OBJECTIVES:
I. Assess patient's perception of factors impacting continuity of care at discharge and after approximately one month from discharge date.
II. Determine the frequency of reported falls and the circumstance surrounding reported falls during hospitalization and within approximately one month from discharge date.
III. Determine the frequency of reported near falls and the circumstance surrounding reported near falls within approximately one month from discharge date.
IV. Identify demographic and clinical characteristics associated with feeling safe and unsafe.
OUTLINE:
Participants complete surveys over 15 minutes at 1-2 days before discharge and at 1 month after discharge.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (survey)
Participants complete surveys over 15 minutes at 1-2 days before discharge and at 1 month after discharge.
Survey Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who provide informed consent
* English-speaking participants
Exclusion Criteria
* Patients with moderate to severe cognitive deficits as determined by speech language pathologist and/or rehabilitation physician
* Patients who were re-hospitalized at any time during study period (since completion of first survey in the hospital and discharged from the hospital until approximately one month after discharge
* Patients who were readmitted to acute inpatient rehabilitation service and previously completed both surveys
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jegy Tennison
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-01749
Identifier Type: REGISTRY
Identifier Source: secondary_id
2018-0104
Identifier Type: OTHER
Identifier Source: secondary_id
2018-0104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.